Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-6-30
pubmed:abstractText
We present four patients, in whom we identified overlapping deletions in 5q14.3 involving MEF2C using a clinical oligonucleotide array comparative genomic hybridization (CGH) chromosomal microarray analysis (CMA). In case 1, CMA revealed an approximately 140 kb deletion encompassing the first three exons of MEF2C in a 3-year-old patient with severe psychomotor retardation, periodic tremor, and an abnormal motor pattern with mirror movement of the upper limbs observed during infancy, hypotonia, abnormal EEG, epilepsy, absence of speech, autistic behavior, bruxism, and mild dysmorphic features. MRI of the brain showed mild thinning of the corpus callosum and delay of white matter myelination in the occipital lobes. In case 2, an approximately 1.8 Mb deletion of TMEM161B and MEF2C was found in a child with severe developmental delay, hypotonia, and seizures. Patient 3 had epilepsy, hypotonia, thinning of the corpus callosum, and developmental delay associated with a de novo approximately 2.4 Mb deletion in 5q14.3 including MEF2C and five other genes. In case 4, a de novo approximately 5.7 Mb deletion of MEF2C and five other genes was found in a child with truncal hypotonia, intractable seizures, profound developmental delay, and shortening of the corpus callosum on brain MRI. These deletions further support that haploinsufficiency of MEF2C is responsible for severe mental retardation, seizures, and hypotonia. Our results, in combination with previous reports, imply that exon-targeted oligo array CGH, which is more efficient in identifying exonic copy number variants, should improve the detection of clinically significant deletions and duplications over arrays with probes spaced evenly throughout the genome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1552-485X
pubmed:author
pubmed:copyrightInfo
(c) 2010 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:volume
153B
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1042-51
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20333642-Base Sequence, pubmed-meshheading:20333642-Child, Preschool, pubmed-meshheading:20333642-Comparative Genomic Hybridization, pubmed-meshheading:20333642-DNA Mutational Analysis, pubmed-meshheading:20333642-Female, pubmed-meshheading:20333642-Gene Deletion, pubmed-meshheading:20333642-Gene Duplication, pubmed-meshheading:20333642-Humans, pubmed-meshheading:20333642-In Situ Hybridization, Fluorescence, pubmed-meshheading:20333642-Infant, pubmed-meshheading:20333642-Infant, Newborn, pubmed-meshheading:20333642-Intellectual Disability, pubmed-meshheading:20333642-MADS Domain Proteins, pubmed-meshheading:20333642-Magnetic Resonance Imaging, pubmed-meshheading:20333642-Male, pubmed-meshheading:20333642-Molecular Sequence Data, pubmed-meshheading:20333642-Muscle Hypotonia, pubmed-meshheading:20333642-Myogenic Regulatory Factors, pubmed-meshheading:20333642-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:20333642-Polymerase Chain Reaction, pubmed-meshheading:20333642-Pregnancy, pubmed-meshheading:20333642-Seizures
pubmed:year
2010
pubmed:articleTitle
Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
pubmed:affiliation
Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't